This is a routine board expansion with no immediate financial implications. Traders should monitor for future committee appointments and any influence from Field's healthcare investment background on strategic decisions.
Price Chart
Executive Summary
Humana Inc. announced the election of Robert S. Field to its Board of Directors, effective after the 2026 Annual Meeting of Stockholders. Field, a healthcare investor and former analyst at Luxor Capital, will serve as an independent director and receive restricted stock units under the company's standard director compensation program.
Key Facts
- Robert S. Field elected to Humana's Board of Directors effective after the 2026 Annual Meeting
- Board expanded from ten to eleven members
- Field qualifies as an independent director under NYSE standards
- Field will receive restricted stock units (RSUs) as part of director compensation
- No committee appointments have been determined yet
Financial Impact
Minimal financial impact; standard director compensation including RSUs will be provided per existing program
Risk Factors
- Potential for activist influence given Field's background as a healthcare investor
- Delayed committee assignments may indicate transitional uncertainty
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000049071-26-000013 |
| Exhibit: exhibit991newsrelease1.htm | 0000049071-26-000013 |
| Document: 0000049071-26-000013-index-headers.html | 0000049071-26-000013 |
| Document: 0000049071-26-000013-index.html | 0000049071-26-000013 |
| Document: 0000049071-26-000013.txt | 0000049071-26-000013 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | 8-K | $394.45 $381.57 | ▼ −3.26% | ▼ −3.58% | $383.50 (−2.78%) |
Aug 17, 2026 6w ago | Institutional Cluster | $382.00 $384.72 | ▲ +0.71% | ▲ +2.02% | $383.50 (+0.39%) |
Aug 13, 2026 7w ago | Court Ruling | $384.97 $409.80 | ▲ +6.45% | ▲ +8.20% | $383.50 (−0.38%) |
Jul 29, 2026 9w ago | 8-K | $365.41 $391.06 | ▲ +7.02% | ▲ +2.00% | $383.50 (+4.95%) |
Jun 1, 2026 17w ago | 8-K | $328.31 $388.90 | ▲ +18.46% | ▲ +20.77% | $383.50 (+16.81%) |
Apr 10, 2026 24w ago | 8-K | $197.53 $274.15 | ▲ +38.79% | ▲ +31.06% | $383.50 (+94.15%) |
Mar 6, 2026 30w ago | DEFA14A | $179.09 $182.71 | ▲ +2.02% | ▲ +4.07% | $383.50 (+114.14%) |
Mar 2, 2026 30w ago | Court Ruling | $187.00 $166.00 | ▼ −11.23% | ▼ −3.29% | $383.50 (+105.08%) |
Mar 2, 2026 30w ago | Court Ruling | $187.00 $166.00 | ▼ −11.23% | ▼ −3.29% | $383.50 (+105.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access